Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis

Abstract

Introduction: Lymphangioleiomyomatosis (LAM) is a rare disease in women, leading to progressive deterioration of lung function and respiratory failure. We describe the outcome of patients with end-stage LAM who underwent lung transplantation at our center. Materials and Methods: The records of patients with LAM transplanted at our institution between February 1997 and May 2015 were reviewed retrospectively. Morbidity and mortality were analyzed, and actuarial survival was calculated using Kaplan-Meier methods. The cumulative survival of transplant patients with LAM at our center was compared with survival after transplantation due to different diseases at our center and the results of the International Society for Heart and Lung Transplantation. Quality of life was assessed by a patient self-report at the end of the first postoperative year. Results: During the study period, 25 patients underwent lung transplantation for LAM. All patients were women with a mean age of 50 (9) years. Thirteen patients (52%) had undergone previous thoracotomy. All patients (100%) received bilateral lung transplantation. One (4%) case of in-hospital mortality occurred and 9 (36%) late deaths. Two (8%) cases of late death were due to chronic lung allograft dysfunction. The 1-, 3-, and 5-year survival rates were 92%, 84%, and 76%, respectively. Quality-of-life ratings were above the normal in all eight 36-Item Short Form Health Survey subscales 1 year after transplantation. Conclusions: Lung transplantation offers a valuable therapy for patients with end-stage pulmonary LAM.

Overview

Integrity signals

Registry

Crossref · 10.1177/1526924819835815

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 15

Metadata

Authors
Salman, J., Ius, F., Sommer, W., Siemeni, T., Fleissner, F., Alhadidi, H., Kugler, C., Avsar, M., Haverich, A., Warnecke, G., Tudorache, I., & Kuhn, C.
Affiliations
  • Medizinische Hochschule Hannover (DE)
  • King Hussein Medical Center (JO)
  • Department of Cardiothoracic, Transplant and Vascular Surgery, Hannover Medical School, Hannover, Germany
Corresponding author
Salman, Jawad
Venue
Progress in Transplantation
Published
2019-05-13
Volume
29
Issue
2
Pages
115-121
ISSN
  • 0905-9199 (ISSN-L)
  • 1526-9248
  • 2164-6708
OpenAlex
W2945670056
Cited by
15
References
23
Citations by year
2026: 1 · 2023: 7 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Progress in Transplantation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
Keywords
lymphangioleiomyomatosis, lung transplantation, bilateral lung transplantation, end-stage lung disease, long-term survival, chronic lung allograft dysfunction, quality of life, respiratory failure, thoracotomy
MeSH terms
Female, Germany, Humans, Lung Neoplasms, Middle Aged, Quality of Life, Retrospective Studies, Survival Rate, Lung Transplantation, Treatment Outcome, Lymphangioleiomyomatosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. https://app.cochat.ai/papers/10.1177/1526924819835815
The paper
Salman, J., Ius, F., Sommer, W., Siemeni, T., Fleissner, F., Alhadidi, H., Kugler, C., Avsar, M., Haverich, A., Warnecke, G., Tudorache, I., & Kuhn, C. (2019). Long-Term Results of Bilateral Lung Transplantation in Patients With End-Stage Pulmonary Lymphangioleiomyomatosis. Progress in Transplantation. https://doi.org/10.1177/1526924819835815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.